The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Zyvox
Linezolid · LINEZOLID 200 mg/100mL · Injection, Solution · Intravenous · Hp Halden Pharma AS
NDC 66298-5137-01 · 100 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- HP Halden Pharma ASNorwaymanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $295.66 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA021131
- TE code
- AP
- Approval date
- Apr 18, 2000
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Linezolid (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Pharmacia & Upjohn Company LLC | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 3, 2026 |
| Caplin Steriles Limited | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 200 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Piramal Critical Care Inc | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | LINEZOLID 200 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Zyvox — NDC 66298-5137-01," retrieved September 3, 2026, https://drugdashboards.com/drug/66298513701.
Free to cite with attribution — see how the data is put together.